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In Brief
Bosch-Bouju et al. used cluster analysis
to segregate mice into anxious and non-
anxious populations following social
defeat. Endocannabinoid spike-timing-
dependent plasticity is abolished in
anxious mice only. Enhancement of
endocannabinoid signaling in the nucleus
accumbens restores anxiety-like
behaviors and synaptic plasticity.
Endocannabinoid plasticity is thus a
synaptic marker of anxiety following
social defeat.
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Chronic social defeat stress (CSDS) is a clinically
relevant model of mood disorders. The relationship
between the CSDS model and a physiologically
pertinent paradigm of synaptic plasticity is not
known. Here, we found that cluster analysis of the
emotional behavior states of mice exposed to
CSDS allowed their segregation into anxious and
non-anxious groups. Endocannabinoid-mediated
spike-timing dependent plasticity (STDP) in the
nucleus accumbens was attenuated in non-anxious
mice and abolished in anxious mice. Anxiety-like
behavior in stressed animals was specifically corre-
lated with their ability to produce STDP. Pharmaco-
logical enhancement of 2-arachidonoyl glycerol
(2-AG) signaling in the nucleus accumbens normal-
ized the anxious phenotype and STDP in anxious
mice. These data reveal that endocannabinoid
modulation of synaptic efficacy in response to a
naturalistic activity pattern is both a molecular corre-
late of behavioral adaptability and a crucial factor in
the adaptive response to chronic stress.
INTRODUCTION
The neural and molecular mechanisms responsible for individual
vulnerability and resilience to neuropsychiatric illnesses such as
depression and anxiety disorders are poorly understood. Endo-
cannabinoids have been linked to psychiatric illness, in particular
the pathophysiology of depressive- and anxiety-like behaviors
(Lafourcade et al., 2011; Hill and Gorzalka, 2009; Hillard et al.,
2012; Mangieri and Piomelli, 2007; Mechoulam and Parker,
2013; Vinod and Hungund, 2006). In depressed patients, blood
levels of endocannabinoids (eCBs) are decreased (Hill et al.,
2009), while in animal models of depression, altered brain levels
of eCBs and functionality of the cannabinoid type 1 receptorCell
This is an open access article under the CC BY-N(CB1R) are reported (Bluett et al., 2014; Hill et al., 2005; Qin
et al., 2015). In addition, pharmacological and genetic disruption
of CB1R or eCB production results in enhanced anxiety, stress,
and fear response (Hill and Patel, 2013; Jenniches et al., 2016;
Marsicano et al., 2002; Qin et al., 2015; Shonesy et al., 2014;
Steiner et al., 2008), reinforcing the idea that this system may
play a significant role in the pathogenesis of neuropsychiatric
diseases.
Endocannabinoids are lipid mediators with essential modula-
tory functions in the brain (Katona and Freund, 2012). Produced
in the postsynapse, the two major eCBs, anandamide and
2-arachidonoyl glycerol (2-AG), signal in a retrograde direction
to modulate synaptic strength via presynaptic CB1R (Castillo
et al., 2012). By integrating and translating environmental
changes into synaptic changes, eCBs regulate a range of brain
functions (for review, see Morena et al., 2016). Activation of
CB1R leads to acute depression of synaptic transmission, which
with extended eCB signaling engages an endocannabinoid-
mediated long-term depression (LTD) originally discovered in
the nucleus accumbens (Robbe et al., 2002), a key structure to
stress resiliency (Duval et al., 2015; Francis et al., 2015; Levita
et al., 2012;McLaughlin et al., 2014; Vialou et al., 2010). However,
it is not known whether eCBs produced in response to a natural-
istic pattern of synaptic activity participate in stress resiliency.
Here, we focused on eCB spike-timing dependent plasticity
(STDP) at excitatory synapses in the accumbens in a clinically
relevant model of anxiety- and depressive-like behaviors:
chronic social defeat stress (CSDS) (Berton et al., 2006; Krishnan
et al., 2007; Larrieu et al., 2014). CSDS induces individual differ-
ences across behavioral endpoints (Krishnan et al., 2007). We
automated classification of behavioral endpoints to segregate
defeated mice based on their anxiety-like behaviors. Our find-
ings demonstrate that impairment of eCB STDP in the accum-
bens is a synaptic signature of anxiety-like behavior after social
defeat stress. The restoration of eCB signaling in the accumbens
through the enhancement of 2-AG signaling protects against
CSDS-induced anxiety-like behavior. Altogether, these data
establish eCB STDP in the accumbens as a central regulator
of adaptive capacity in animals exposed to CSDS, offering aReports 16, 1237–1242, August 2, 2016 ª 2016 The Authors. 1237
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Behavioral Clustering in Socially
Defeated Mice
(A–D) Behavioral portraits of undefeated mice
(white) and defeated mice (red) show increased
anxiety in defeated mice. *p < 0.05, unpaired t test.
Data are presented as mean ± SEM. (A) Time in the
interaction zone. Undefeated: 127 ± 11 s, n = 19;
defeated: 96 ± 8 s, n = 34. t51 = 2.336, *p = 0.0235.
(B) Time in the center of the open field. Unde-
feated: 11.3% ± 1.2%, n = 19; defeated: 9.0% ±
0.8%, n = 36. t53 = 1.570, p = 0.1223. (C) Time in the
light compartment. Undefeated: 260 ± 16 s, n = 19;
defeated: 198 ± 12 s, n = 37. t54 = 3.048, *p = 0.036.
(D) Time in open arms of the elevated plus maze.
Undefeated: 17.5% ± 1.4%, n = 19; defeated:
13.2% ± 1.1%, n = 37. t54 = 2.385, *p = 0.0208.
(E) Clustering analysis of socially defeated mice’s
behavior reveals a dendrogram with two clusters
corresponding to anxious animals ( red) and non-
anxious animals (black).
(F) Normalized average values for all behavioral
parameters of the cluster analysis in anxious
and non-anxious groups. Data are presented as
mean ± SEM. From left to right, non-anxious
(n = 18) versus anxious (n = 18), respectively: SA,
social avoidance test, 0.60 ± 0.05 versus 0.54 ±
0.06; OF, open field test, 0.28 ± 0.05 versus 0.19 ±
0.04; L/D, light/dark box test, 0.72 ± 0.04 versus
0.44 ± 0.04; EPM, elevated plus maze test, 0.56 ±
0.04 versus 0.21 ± 0.03. *p < 0.05, two-way
ANOVA with Bonferroni post-test, with cluster
(F(1,105) = 42.96, p < 0.0001) and behavioral
parameter (F(3,105) = 29.99, p < 0.0001) as factors.
Interaction: F(3,105) = 5.39, p = 0.0017.pharmacologically amenable mechanism to promote resiliency
to stressful events.
RESULTS
Segregation of Defeated Animals into Anxious and
Non-anxious Populations Using Cluster Analysis
Naive C57BL/6J mice were subjected to ten daily bouts of social
defeat by an aggressive CD1 male mouse. CSDS is known to
induce individual differences to stress responses, and defeated
animals can be separated into susceptible and resilient based on
the measure of their social interaction (Figure S1) (Golden et al.,
2011; Krishnan et al., 2007). In the present study, we used an
alternative method to segregate defeated mice based on their
emotional behaviors in open field, social avoidance, light/dark
box, and elevated plus maze tests (Figures 1A–1D; Figure S2).
This unbiased cluster analysis approach revealed that defeated
mice can be segregated in two populations based on their
emotional behaviors (Figure 1E): 52% of defeated mice showed
severe anxiety-like behaviors and were hereafter labeled
anxious, while the remaining 48% that display anxiety-like
behaviors similar to those of undefeated mice were labeled
non-anxious. By comparison with the classical segregation of
susceptible and resilient mice, we found that 50% of resilient
and 55% of susceptible mice were anxious (Figure S1). Conse-
quently, both anxious and non-anxious mice displayed an in-
crease in social avoidance following CSDS, but only anxious1238 Cell Reports 16, 1237–1242, August 2, 2016mice exhibited elevated anxiety-like behaviors, as revealed by
an aversion to the open arms of an elevated plus maze and the
light compartment of a light/dark box (Figure 1F; Figure S2).
Anxious and non-anxious mice displayed a similar increase in
plasma corticosterone levels, adrenal weight, and body weight
(Figure S2), suggesting that the two populations of defeated
mice do not differ in their metabolic stress response.
Endocannabinoid Spike-Timing Dependent Depression
Covariates with Anxiety-like Behavior
We next analyzed the consequences of CSDS on synaptic
Hebbian learning in the accumbens, a key structure that contrib-
utes to the etiology of mood and anxiety disorders (Bagot et al.,
2015; Calhoon and Tye, 2015; Shin et al., 2015; Vialou et al.,
2010). We first established that CB1R mediates Hebbian STDP
(Abbott and Nelson, 2000; Fino et al., 2010) in the accumbens.
In undefeated mice, presynaptic stimulation of 100 pairings
at 1 Hz coupled to a single postsynaptic spike delayed by
15 ms induced significant LTD (51% of baseline) of excitatory
postsynaptic currents (EPSCs) (Figures 2A–2C). As expected
for eCB-mediated plasticity, the CB1R antagonists AM251 and
SR141716A both blocked STDP-LTD (Figure S3). In anxious
mice, STDP-LTD was abolished (111% of baseline) (Figure 2A).
Non-anxious mice displayed an intermediary phenotype:
STDP-LTD was attenuated but still present (83% of baseline)
(Figures 2A–2C). In the bed nucleus of the stria terminalis, stress
transforms CB1R-dependent LTD to long-term potentiation
Figure 2. Spike-Timing-Dependent LTD Is a
Synaptic Marker in Anxious Mice
(A) Time course of STDP-LTD in undefeated (white),
non-anxious (black), and anxious (red) mice. EPSC
normalized amplitude 45 min after STDP. Unde-
feated: 51.28% ± 4.36%, n = 16; non-anxious:
82.13% ± 4.32%, n = 18; anxious: 110.80% ±
8.71%, n = 18. *p < 0.05, two-way ANOVA with
Bonferroni post-test, with group (F(2,512) = 104.99,
p < 0.0001) and time (F(10,512) = 5.11, p < 0.0001) as
factors. Interaction: F(20,512) = 2.90, p < 0.0001.
Data are presented as mean ± SEM. Illustration
traces: example of ten averaged EPSCs during
baseline (left) and 45 min after STDP (right). Upper
(gray), undefeated; middle (black), non-anxious;
bottom (red), anxious. Scale bar, 50 pA, 10 ms.
(B) Cumulative probability distribution of normal-
ized EPSCs after STDP protocol. Same color code
as (A).
(C) EPSCs before and after STDP-LTD induction
for undefeated (white), non-anxious (black), and
anxious (red) mice. No defeat: before, 177 ±
21 pA, versus after, 88 ± 14 pA; n = 16,
p < 0.0001. Non-anxious: before, 181 ± 22 pA,
versus after, 150 ± 22 pA; n = 18, p = 0.0025.
Anxious: before, 175 ± 19 pA, versus after,
190 ± 26 pA; n = 18, p = 0.3365. Each line
represents one neuron, *p < 0.05, paired t test.
(D) The anxiety score positively correlates with
the expression of LTD (r2 = 0.1222, p = 0.0339,
Pearson test). Each dot represents one mouse.(LTP) (Glangetas et al., 2013). Our data support this idea that the
STDP protocol triggered LTD in all and 55% of the neurons from
undefeated and non-anxious mice, respectively, in contrast to
anxious mice, among which only 11% of the neurons expressed
LTD and up to 33% exhibited LTP (LTD threshold, 85% of base-
line EPSC; LTP threshold, 115%) (Figure 2B). To strengthen the
association between eCB-mediated plasticity and anxiety, we
computed an anxiety score and found that this behavioral index
positively correlatedwith eCB-LTD in theaccumbens (Figure 2D).
Specifically, eCB-LTD was significantly correlated with anxiety
measured in open field, light/dark box, and elevated plus maze
tests (Table S1). In contrast, we did not observed a correlation
between eCB-LTD and corticosterone levels in defeated mice
(Figure S3). These data suggest that both groups experienced
similar levels of neuroendocrine stress response and dissociate
general hypothalamic-pituitary-adrenal axis reactivity to stress
from social defeat stress-induced eCB-plasticity deficits. Basic
intrinsic and synaptic properties of accumbens output neurons
were similar in anxious and non-anxious mice (Figure S3),
suggesting that modification of neuronal excitability or network
activity is a minor contributor to the lack of eCB-mediated
plasticity.
Pharmacological Enhancement of eCB Signaling
Normalizes Both Anxiety-related Behavior and Synaptic
Plasticity within the Accumbens
We next investigated whether upregulation of 2-AG signaling
could normalize anxiety-like behavior and eCB-LTD in defeated
mice. We used JZL184, a monoacylglycerol lipase (MAGL) inhib-
itor, to prevent 2-AG degradation and increase its accumulationat the synapse (Jung et al., 2012). Mice treated with JZL184
(16 mg/kg, intraperitoneal [i.p.]) 1 day after the last session of
CSDS showed anxiety-like behavior that was undistinguishable
from that of undefeated mice (Figure 3A). To discern the contri-
bution of 2-AG elevation within the accumbens in the systemic
effects of JZL184, we repeated experiments directly infusing
theMAGL inhibitor into the accumbens (1 mg, 0.5 ml/side). Similar
to the systemic protocol, local infusion of JZL184 prevented anx-
iety-like behaviors in defeated mice (Figure 3C). We also found
that JZL184 (1 mM) restored eCB-LTD in defeated mice (Figures
3B–3D; Figure S3), reinforcing the link between eCB-mediated
STDP-LTD in the accumbens and behavioral anxiety following
CSDS. As a control, the effect of JZL184 on STDP-LTD was
blocked by the CB1R antagonist SR141716A (Figure S3). Alto-
gether, these data favor the idea that elevation of 2-AG in the ac-
cumbens can normalize anxiety behavior in defeated mice.
DISCUSSION
There is a considerable interest in understanding neurobiological
correlates of adaptive response and resiliency to chronic
social stress. In the current study, we provide clear evidence
that eCB-mediated Hebbian learning at medium spiny neuron
excitatory synapses in the nucleus accumbens contributes to
behavioral adaptations to social stress. Furthermore, our results
indicate that this synaptic plasticity is a pharmacologically
targetable neurobiological mechanism that may promote resis-
tance to anxiety following chronic stress.
A unique feature of CSDS, distinguishing it from other environ-
mental stressors, is that CSDS induces a range of individualCell Reports 16, 1237–1242, August 2, 2016 1239
Figure 3. Enhancement of Circulating 2-AG Normalizes Anxious
Behavior and Synaptic Depression in Defeated Mice
(A) A single injection of JZL184 (16 mg/kg) is sufficient to restore a normal
anxiety-like behavior. Elevated plus maze (EPM) score is the average of
normalized measures for number of head dippings, percentage of time in the
open arms, and number of entries in the open arms. Undefeated: 0.94 ± 0.13,
n = 6; defeated: 0.38 ± 0.09, n = 6; undefeated + JZL184: 0.64 ± 0.04, n = 4;
defeated + JZL184: 0.67 ± 0.01, n = 3. Two-way ANOVA with Bonferroni post-
test, with JZL184 (F(1,15) = 0.0005, p = 0.9821) and CSDS (F(1,15) = 5.983),
p = 0.0273) as factors. Interaction: F(1,15) = 7.713, p = 0.0141. *p < 0.05.
(B) Infusion of JZL184 bilaterally in the nucleus accumbens also restores
anxiety behavior of defeated mice. EPM score. Defeated: 0.39 ± 0.08, n = 7;
defeated + JZL184NAc: 0.70 ± 0.06, n = 7. t13 = 3.158, *p = 0.0076, unpaired
t test.
(C) Time course of STDP-LTD in defeated mice without JZL184 (red) and with
JZL184 (purple). EPSC normalized amplitude 45 min after STDP. Defeated:
96.88% ± 5.36%, n = 36; defeated + JZL184: 55.13% ± 4.96%, n = 22.
*p < 0.05, two-way ANOVA with Bonferroni post-test, with JZL184 (F(1,572) =
140.07, p < 0.0001) and time (F(10,572) = 8.08, p < 0.0001) as factors. Interaction:
F(10,572) = 4.02, p < 0.0001. Illustration traces: example of ten averaged EPSCs
during baseline (left) and 45 min after STDP (right). Scale bar, 100 pA, 10 ms.
(A–C) Data are presented as mean ± SEM.
1240 Cell Reports 16, 1237–1242, August 2, 2016responses (Golden et al., 2011; Krishnan et al., 2007) similar to
those observed after traumatic stress in humans. This particular-
itymakes CSDS in rodents a useful model for studying themech-
anisms that underlie anxiety and depression onset. Here, we
used several measures of emotional behavior to classify a pop-
ulation of CSDS-exposed mice into anxious and non-anxious
groups using cluster analysis. Using this approach, we identified
a non-anxious set of CSDS animals corresponding to approxi-
mately half of the entire population that failed to develop
anxiety-related behavior and exhibited a behavioral phenotype
comparable to that of undefeated mice. Both anxious and non-
anxious mice showed strong generalized social avoidance.
This study therefore reports individual differences in anxiety-
like behaviors in mice exposed to CSDS. In the nucleus accum-
bens, CB1R is expressed at both excitatory and inhibitory
synapses (Pickel et al., 2004). However, STDP protocol requires
activation of pre- and post-synaptic elements of the stimulated
synapses, which rules out the contribution of interneurons’ plas-
ticity in the observed STDP-LTD.
It has been previously reported that anxiety-like behavior may
be correlated to levels of eCBs in the brain (Hill and Patel, 2013;
Qin et al., 2015), but the effects on the eCB synaptic plasticity
remained unexplored. In our study, we demonstrated that anxi-
ety behavior induced by CSDS covariates with eCB-dependent
plasticity. Here, we used a STDP protocol to reveal the function-
ality of the eCB system. Hebbian synaptic plasticity induced by
STDP has been described in intact brains in the human cortex
and in sensory systems and is thought to be a neurobiological
basis for associative learning (Letzkus et al., 2007). However,
the significance of STDP in non-sensory or motor systems re-
mains to be clarified. We demonstrated that non-anxious mice
display an attenuation in eCBSTDP but that this form of plasticity
is abolished in anxious mice. This suggests that eCB Hebbian
plasticity constitutes a system for adaptive synaptic plasticity
in the accumbens that allows behavioral adaptability and thus
avoids the development of strong anxiety-like behavior following
CSDS.
The role of the eCB system in stress and anxiety disorders
may rely on its reciprocal interactions with the hypothalamic-
pituitary-adrenal axis, which is responsible for stress response
in the body (Gorzalka and Hill, 2009; Hill and Tasker, 2012;
McEwen et al., 2015). It has been previously shown that
stress-induced modulation of corticosterone affects the eCB
system in the amygdala and the hypothalamus (Gray et al.,
2015; Qin et al., 2015; Wamsteeker et al., 2010). In the current
study, basal corticosterone levels were increased in both
anxious and non-anxious defeated groups, without apparent
correlation to the level of eCB-LTD. Whether hypothalamic-pitu-
itary-adrenal axis reactivity due to acute stressmight be different
between groups has yet to be determined, but this is a focus of
future research for our group. Recent findings report preexisting
individual differences in the peripheral immune system that(D) EPSC amplitude before and after STDP protocol for defeated mice with
JZL184 bath application. Before, 233 ± 32 pA, versus after, 131 ± 25 pA;
n = 22, *p < 0.0001, paired t test. Each line represents one neuron.
(E) Cumulative probability distribution of normalized EPSCs after STDP pro-
tocol. Same color code as (C).
predict and promote stress susceptibility (Hodes et al., 2014).
In our study, innate differences in the functionality of the eCB
system could be responsible for vulnerability to social defeat-
induced emotional alteration.
The lack of eCB plasticity in anxious mice may arise from
reduced eCB levels. Reduction in circulating levels of the eCB
2-AG has been found in individuals exposed to traumatic stress,
as well as in rodents exposed to chronic stress (Hill et al., 2009),
while enhancement of 2-AG levels increases behavioral resil-
iency to chronic stress in mice (Zhang et al., 2015; Zhong
et al., 2014). Thus, we tested whether increased anxiety-related
behavior could be overcome by enhancing 2-AG signaling, the
main endocannabinoid involved in LTD in the accumbens (Cas-
tillo et al., 2012). We found that pharmacological blockade of
intracellular 2-AG hydrolysis in mice subjected to CSDS allevi-
ated the anxiety-related behavior and restored eCB-dependent
plasticity in a CB1R-dependent manner. This suggests that
CSDS-induced anxiety alters the bioavailability of eCB.
In conclusion, we found that impairment of eCB plasticity in
the accumbens is a synaptic signature for behavioral adaptability
following social stress. The restoration of eCB signaling through
the improvement of 2-AG signaling protects against CSDS-
induced anxiety-like behavior. Finally, exploring emotional pro-
cesses at the synaptic level would lead to a better understanding
of how chronic stress affects our brain and offer a pharmacolog-
ically amenable mechanism to promote resiliency to stressful
events.
EXPERIMENTAL PROCEDURES
CSDS and Behavioral Testing
All experiments were performed according to criteria of the European Commu-
nities Council Directive (50120103-A) on C57BL/6J adult male mice. The social
defeat protocol was performed as previously described (Larrieu et al., 2014).
Behavioral tests were performed 24–48 hr after the last session of social defeat
using a social avoidance test, open field test, light/dark box test, and elevated
plus maze test (see supplemental Information for details).
The anxiety score was calculated as the algebraic sum of standardized
scores ((x  min value) / (max value  min value)) of each of the six analyzed
parameters of the three anxiety-related behavior tests. When more than one
parameter was used for one test, normalized values of parameters were aver-
aged so that the power of each of the three anxiety tests was equal to 1. This
procedure yields scores that are distributed along a scale from 0 to 3, with 3
reflecting high anxiety.
Electrophysiology
Brain slices were prepared 24 hr after the last behavioral test for each animal.
Signals were amplified and recorded with Multiclamp 700B, controlled with
pClamp 10.3 software via a Digidata 1440A interface (Molecular Devices).
STDP protocol consists of pairing pre- and postsynaptic stimulations 100
times at 1 Hz, with a delay of 15 ms and the neuron held at 70 mV in the
current clamp configuration. Medium spiny neurons were recorded for
10 min of stable baseline (0.1 Hz) and for at least 35 min after the STDP proto-
col. Chemicals used were AM251 (4 mM), SR141716A (1 mM), and JZL184
(1 mM).
In Vivo Pharmacological Experiments
For JZL184 i.p. injections, mice were given i.p. injections of vehicle (22.5:100
HBC:H2O) or JZL184 (16 mg/kg) 6 hr before the elevated plus maze test. For
JZL injections in the nucleus accumbens, animals were implanted 1 week
before CSDS started with bilateral guide cannulas (PlasticsOne) 1 mm above
the nucleus accumbens. JZL184 (1 mg/0.5 ml DMSO 10% in saline/hemisphere)or vehicle was injected into the nucleus accumbens 1 hr before the elevated
plus maze test.
Statistical Analyses
Statistical tests were performedwith Prism (GraphPad) using a critical probabil-
ity of p < 0.05. All values are given as mean ± SEM. The dendrogram was ob-
tainedwith XLStat (Addinsoft) using centroid hierarchical cluster analysis (Eucli-
dienne distance and Ward method) to separate the defeated mice into anxious
and non-anxious phenotypes. See Supplemental Information for details.
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